EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,073,630 | +1.9% | 106,300 | 0.0% | 0.06% | +57.1% |
| Q3 2022 | $1,054,000 | +1.3% | 106,300 | 0.0% | 0.04% | +9.4% |
| Q2 2022 | $1,040,000 | -28.8% | 106,300 | -29.1% | 0.03% | -22.0% |
| Q1 2022 | $1,461,000 | +0.5% | 150,000 | 0.0% | 0.04% | +5.1% |
| Q4 2021 | $1,454,000 | +0.2% | 150,000 | 0.0% | 0.04% | -20.4% |
| Q3 2021 | $1,451,000 | +0.1% | 150,000 | 0.0% | 0.05% | -9.3% |
| Q2 2021 | $1,449,000 | – | 150,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |